The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

II.a

Pulmonary edema, noncardiogenic (NCPE)

Publications

Dolan N, Waldron M, O'Connell M, Eustace N, Carson K, Awan A

Basiliximab induced non-cardiogenic pulmonary edema in two pediatric renal transplant recipients.

Pediatric nephrology (Berlin, Germany) 2009 Nov;24;2261-5 — 2009 Nov — 2261-5

Bamgbola FO, Del Rio M, Kaskel FJ, Flynn JT

Non-cardiogenic pulmonary edema during basiliximab induction in three adolescent renal transplant patients.

Pediatric transplantation 2003 Aug;7;315-20 — 2003 Aug — 315-20